ORLANDO, Fla. – A third, easier-to-use coronavirus vaccine is nearing its final approval. The Food and Drug Administration’s scientists confirmed Johnson & Johnson’s vaccine is about 66% effective at preventing moderate to severe COVID-19. [TRENDING: Tiger Woods’ leg shattered in rollover crash | Orlando City player faces sex charge | Woman loses $100,000 to romance conman] The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.
J&J previously announced the vaccine worked better in the U.S. -- 72% effective against moderate to severe COVID-19, compared with 66% in Latin America and 57% in South Africa.